AMPA 2 Inhibitors

Chemical inhibitors of AMPA 2 include a variety of compounds that target the receptor's functionality in different ways. NBQX is a competitive antagonist that binds directly to the glutamate binding site of the AMPA 2 receptor, which results in the inhibition of the excitatory signals that are otherwise mediated by glutamate's action on the receptor. Another compound, GYKI 52466, functions as a non-competitive antagonist, altering the receptor's ion channel properties, thus inhibiting the ion flow and the subsequent neuronal excitation. Perampanel also selects for AMPA 2 receptors, but it does so by binding to an allosteric site, which prevents the ion channel from opening and reduces excitatory neurotransmission. IEM-1460 specifically targets calcium-permeable AMPA 2 receptors, blocking them and consequently inhibiting excitatory synaptic transmission.

Tezampanel and Becampanel work by competitively antagonizing the glutamate recognition site on AMPA 2 receptors, inhibiting receptor activation and the following excitatory neurotransmission. CFM-2 and ZK200775 both bind to allosteric modulatory sites on AMPA 2 receptors, inhibiting the receptor's ionotropic activity, which silences the excitatory signals normally transmitted. Topiramate indirectly affects AMPA 2 receptor-mediated responses by modulating the receptor subunit composition, which influences the ion channel properties and inhibits excitatory neurotransmission. Talampanel and Selurampanel, much like Tezampanel and Becampanel, prevent glutamate from activating AMPA 2 receptors by antagonizing the glutamate-binding site, thereby inhibiting the receptor's activity. Lastly, Ifenprodil, although it is primarily a modulator of NMDA receptors, can inhibit AMPA 2 receptors when they are associated with specific subunits, leading to a decrease in excitatory neurotransmission facilitated by these receptors.